- Home
- PBYI vs SPIR Comparison
PBYI vs SPIR Comparison
Compare PBYI & SPIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- SPIR
- Stock Information
- Founded
- PBYI 2010
- SPIR 2012
- Country
- PBYI United States
- SPIR United States
- Employees
- PBYI N/A
- SPIR N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- SPIR Telecommunications Equipment
- Sector
- PBYI Health Care
- SPIR Consumer Discretionary
- Exchange
- PBYI Nasdaq
- SPIR Nasdaq
- Market Cap
- PBYI 153.2M
- SPIR 348.5M
- IPO Year
- PBYI N/A
- SPIR N/A
- Fundamental
- Price
- PBYI $3.09
- SPIR $13.07
- Analyst Decision
- PBYI Strong Buy
- SPIR Strong Buy
- Analyst Count
- PBYI 1
- SPIR 6
- Target Price
- PBYI $7.00
- SPIR $19.20
- AVG Volume (30 Days)
- PBYI 754.5K
- SPIR 255.7K
- Earning Date
- PBYI 02-27-2025
- SPIR 03-05-2025
- Dividend Yield
- PBYI N/A
- SPIR N/A
- EPS Growth
- PBYI 492.79
- SPIR N/A
- EPS
- PBYI 0.47
- SPIR N/A
- Revenue
- PBYI $243,569,000.00
- SPIR $107,223,000.00
- Revenue This Year
- PBYI N/A
- SPIR $18.02
- Revenue Next Year
- PBYI N/A
- SPIR $13.78
- P/E Ratio
- PBYI $6.63
- SPIR N/A
- Revenue Growth
- PBYI 6.30
- SPIR 24.15
- 52 Week Low
- PBYI $2.23
- SPIR $6.26
- 52 Week High
- PBYI $7.73
- SPIR $19.40
- Technical
- Relative Strength Index (RSI)
- PBYI 49.17
- SPIR 43.21
- Support Level
- PBYI $2.92
- SPIR $12.66
- Resistance Level
- PBYI $4.06
- SPIR $15.78
- Average True Range (ATR)
- PBYI 0.29
- SPIR 0.87
- MACD
- PBYI 0.01
- SPIR -0.19
- Stochastic Oscillator
- PBYI 27.07
- SPIR 13.16
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About SPIR Spire Global Inc.
Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.